At least one third of all cases of epithelial ovarian cancer are associated with the production of ascites, although its effect on tumor cell microenvironment remains poorly understood. This study addresses the effect of the heterologous acellular fraction of ovarian cancer-derived ascites on a cell line (OV-90) derived from the chemotherapy-naive ovarian cancer patient. Ascites were assayed for their effect on cell invasion, growth, spheroid formation. When compared to either no serum or 5% serum, ascites fell into one of two categories: stimulatory or inhibitory. RNA from OV-90 cells exposed to selected ascites were arrayed on an Affymetrix HG-U133A GeneChip. A supervised analysis identified a number of differentially expressed genes, qua...
<p>Most ovarian cancer patients at diagnosis (stage IIIc/IV) present with ascites (CN) which consist...
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy and has a unique metastati...
Ovarian cancer is one of the most lethal gynaecological diseases worldwide, and in Norway approximat...
AbstractAt least one third of all cases of epithelial ovarian cancer are associated with the product...
More than one third of ovarian cancer patients present with ascites at diagnosis, and almost all hav...
AbstractA third of patients with epithelial ovarian cancer (EOC) present ascites. The cellular fract...
Abstract Background Malignant ascites often develops in advanced stages of ovarian carcinoma, consis...
Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an at...
Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an at...
Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an at...
Chemotherapy resistance is the major reason for the failure of ovarian cancer treatment. One mechani...
Ascites refers to the abnormal accumulation of fluid in the peritoneum resulting from an underlying ...
Abstract Background Epithelial ovarian cancer is the second most lethal gynecological cancer worldwi...
Ovarian cancer is the most lethal gynaecological malignant disease, mainly due to late diagnosis and...
Abstract Background At least one-third of epithelial ovarian cancers are associated with the develop...
<p>Most ovarian cancer patients at diagnosis (stage IIIc/IV) present with ascites (CN) which consist...
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy and has a unique metastati...
Ovarian cancer is one of the most lethal gynaecological diseases worldwide, and in Norway approximat...
AbstractAt least one third of all cases of epithelial ovarian cancer are associated with the product...
More than one third of ovarian cancer patients present with ascites at diagnosis, and almost all hav...
AbstractA third of patients with epithelial ovarian cancer (EOC) present ascites. The cellular fract...
Abstract Background Malignant ascites often develops in advanced stages of ovarian carcinoma, consis...
Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an at...
Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an at...
Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an at...
Chemotherapy resistance is the major reason for the failure of ovarian cancer treatment. One mechani...
Ascites refers to the abnormal accumulation of fluid in the peritoneum resulting from an underlying ...
Abstract Background Epithelial ovarian cancer is the second most lethal gynecological cancer worldwi...
Ovarian cancer is the most lethal gynaecological malignant disease, mainly due to late diagnosis and...
Abstract Background At least one-third of epithelial ovarian cancers are associated with the develop...
<p>Most ovarian cancer patients at diagnosis (stage IIIc/IV) present with ascites (CN) which consist...
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy and has a unique metastati...
Ovarian cancer is one of the most lethal gynaecological diseases worldwide, and in Norway approximat...